Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Auction rates moved to marketable securities page F-3

Auction rates moved to marketable securities page F-3

posted on Aug 14, 2008 12:58PM

I defer to Fut but you may notice on the balance sheet on page F-3 a substantial drop in Cash and Cash Equvalents from 2007 to 2008 from $21.6 million to $6.4 million.

I believe that is because the $12.5 million in ARS has been moved to "Marketable Securities" for 2008.



So our Cash and Cash Equvalents is around $18.9 million, slightly lower than 2007.

Share
New Message
Please login to post a reply